Their plan is the culmination of a yearlong listening tour on the dangers of the new technology.
OpenAI and the FDA are reportedly discussing AI for drug evaluations
- today, 5:09 PM
- techcrunch.com
- 0

Their plan is the culmination of a yearlong listening tour on the dangers of the new technology.
No comments